☆ 4.6 Editorial Material

Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care

PLOS MEDICINE (2018)

Journal

PLOS MEDICINE

Volume 15, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE

DOI: 10.1371/journal.pmed.1002545

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Oncology

Cancer care for people with dementia: Literature overview and recommendations for practice and research

Laura Ashley, Claire Surr, Rachael Kelley, Mollie Price, Alys Wyn Griffiths, Nicole R. Fowler, Dana E. Giza, Richard D. Neal, Charlene Martin, Jane B. Hopkinson, Anita O'Donovan, William Dale, Bogda Koczwara, Katie Spencer, Lynda Wyld

Summary: With the aging population, cancer patients are getting older and more likely to have preexisting comorbidities, such as dementia. People with dementia are vulnerable to health disparities, which can complicate cancer care and outcomes.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Article Medicine, General & Internal

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings

Michael K. Sullivan, Bhautesh Dinesh Jani, Alex McConnachie, Peter Hanlon, Philip McLoone, Barbara I. Nicholl, Juan-Jesus Carrero, Dorothea Nitsch, David McAllister, Frances S. Mair, Patrick B. Mark

Summary: This study aimed to examine hospitalisation rates in people with multimorbidity with and without CKD, and to identify risk factors for hospitalisation among CKD patients. The research found that individuals with multimorbidity, especially with CKD, have higher rates of hospitalisation, emphasizing the need for further research into strategies to prevent hospitalisation in this high-risk group.

BMC MEDICINE (2021)

Add to Collection

Article Chemistry, Analytical

Advances in Photoplethysmography for Personalized Cardiovascular Monitoring

Seamin Kim, Xiao Xiao, Jun Chen

Summary: Photoplethysmography (PPG) is gaining popularity for diagnosing cardiovascular diseases due to its low cost and noninvasiveness. Simple analysis of PPG signals can provide information such as heart rate, while complex analysis can yield valuable insights into blood pressure and heart rate variability. Understanding the sources of noise is crucial for obtaining reliable information to assess cardiovascular health.

BIOSENSORS-BASEL (2022)

Add to Collection

Review Medicine, Research & Experimental

Resveratrol (RV): A pharmacological review and call for further research

Li-Xue Zhang, Chang-Xing Li, Mohib Ullah Kakar, Muhammad Sajjad Khan, Pei-Feng Wu, Rai Muhammad Amir, Dong-Fang Dai, Muhammad Naveed, Qin-Yuan Li, Muhammad Saeed, Ji-Qiang Shen, Shahid Ali Rajput, Jian-Hua Li

Summary: Resveratrol (RV) is a polyphenolic compound found in various plants known for its association with health benefits such as anti-obesity, cardioprotective, neuroprotective, antitumor, antidiabetic, antioxidants, anti-age effects, and glucose metabolism. It has therapeutic properties in cancer, neurodegeneration, and atherosclerosis, and also shows antibacterial effects.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Chronic Kidney Disease and Cardiovascular Disease: A Personalized Approach

Ashton C. Lai, Solomon W. Bienstock, Raman Sharma, Karl Skorecki, Frans Beerkens, Rajeev Samtani, Andrew Coyle, Tonia Kim, Usman Baber, Anton Camaj, David Power, Valentin Fuster, Martin E. Goldman

Summary: Cardiovascular disease is the leading cause of death in end-stage renal disease patients, exacerbated by dialysis treatment. Multimodality imaging may offer additional prognostication and risk stratification for these patients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Trends in Cardiometabolic and Cancer Multimorbidity Prevalence and Its Risk With All-Cause and Cause-Specific Mortality in U.S. Adults: Prospective Cohort Study

Liu Yang, Jiahong Sun, Min Zhao, Costan G. Magnussen, Bo Xi

Summary: Several prospective cohort studies have shown inconsistent findings regarding the association between multimorbidity and all-cause mortality. This study utilized data from the National Health Interview Survey (1997-2014) to examine the trends in prevalence of multimorbidity and its impact on all-cause and cause-specific mortality in the U.S. population. The results indicate a significant increase in prevalence of multimorbidity and a higher risk of mortality, particularly in individuals with multiple chronic conditions, suggesting the need for effective prevention and intervention programs to address this issue.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Immunology

Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study

Tiffany E. Gooden, Mike Gardner, Jingya Wang, Kate Jolly, Deirdre A. Lane, Laura A. Benjamin, Henry C. Mwandumba, Vanessa Kandoole, Isaac B. Lwanga, Stephen Taylor, Semira Manaseki-Holland, Gregory Y. H. Lip, Krishnarajah Nirantharakumar, G. Neil Thomas

Summary: People with HIV are at increased risk for cardiovascular disease and common risk factors, highlighting the importance of regular screening for these conditions.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Targeting endothelial cells with golden spice curcumin: A promising therapy for cardiometabolic multimorbidity

Fei Tang, Dong Liu, Li Zhang, Li-Yue Xu, Jing-Nan Zhang, Xiao-Lan Zhao, Hui Ao, Cheng Peng

Summary: Cardiometabolic multimorbidity is a significant global public health concern, and curcumin shows promise as a potential treatment option through its regulation of endothelial function.

PHARMACOLOGICAL RESEARCH (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease

Yeela Talmor-Barkan, Noam Bar, Aviv A. Shaul, Nir Shahaf, Anastasia Godneva, Yuval Bussi, Maya Lotan-Pompan, Adina Weinberger, Alon Shechter, Chava Chezar-Azerrad, Ziad Arow, Yoav Hammer, Kanta Chechi, Sofia K. Forslund, Sebastien Fromentin, Marc-Emmanuel Dumas, S. Dusko Ehrlich, Oluf Pedersen, Ran Kornowski, Eran Segal

Summary: Multi-omic profiling of patients with coronary artery disease reveals links between alterations in the serum metabolome with genetics, diet, and the microbiome. The study found that these metabolomic alterations are associated with metabolic impairment preceding clinically overt coronary artery disease. The results highlight the importance of understanding risk-factor heterogeneity in coronary artery disease through the serum metabolome.

NATURE MEDICINE (2022)

Add to Collection

Article Pharmacology & Pharmacy

A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia

Andrea L. Schaffer, Joel Chia, Jonathan Brett, Sallie-Anne Pearson, Michael O. Falster

Summary: Multimedicine use is common in people treated with cardiovascular medicines and presents a risk for inappropriate prescribing. The dispensing rate of cardiovascular medicines increases with age, while the impact of gender is relatively small. People generally need to use 2 cardiovascular medicines at the same time, while older people may need to use more medicines to treat multiple conditions.

PHARMACOTHERAPY (2022)

Add to Collection

Review Pharmacology & Pharmacy

An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care

Zoufang Huang, Vivek P. Chavda, Rajashri Bezbaruah, Vladimir N. Uversky, P. Sucharitha, Aayushi B. Patel, Zhe-Sheng Chen

Summary: Originating in ancient India, Ayurveda is an alternative medicinal approach that provides new insights into personalized medicine through its combination with genomics. Based on three Prakriti aspects, Ayurvedic methodologies can help improve life quality and prevent diseases.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Membranous Nephropathy: From Research Bench to Personalized Care

Barbara Moszczuk, Krzysztof Kiryluk, Leszek Paczek, Krzysztof Mucha

Summary: Membranous nephropathy is a glomerulopathy that leads to nephrotic syndrome and end-stage kidney disease, with recent scientific advancements opening up new possibilities for diagnosis and personalized treatment. By utilizing serological/immunological methods, genomic and proteomic studies, there is potential for a more individualized approach to treating membranous nephropathy.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Clustering and Healthcare Costs With Multiple Chronic Conditions in a US Study

Cother Hajat, Yakir Siegal, Amalia Adler-Waxman

Summary: The study shows that over 57% of insured patients in the US may have multiple chronic conditions (MCCs). Clustering of MCCs is common and associated with healthcare utilization.

FRONTIERS IN PUBLIC HEALTH (2021)

Add to Collection

Article Geriatrics & Gerontology

Local, collaborative, stepped, and personalized care management for older people with chronic diseases - results from the randomized controlled LoChro-trial

Gloria Metzner, Lukas Maximilian Horstmeier, Juergen Bengel, Eva Maria Bitzer, Elena Dreher, Fabian Frank, Anne Goehner, Bernhard Heimbach, Ines Himmelsbach, Klaus Kaier, Jasmin Kiekert, Katharina Kohler, Katharina Laubner, Lisa Lyssenko, Andy Maun, Christoph Maurer, Claudia Salm, Jochen Seufert, Sebastian Voigt-Radloff, Erik Farin-Glattacker

Summary: In the aging population of Western societies, an increasing number of older adults have multiple chronic diseases. We developed a local, collaborative, stepped, and personalized care management approach (LoChro-Care) to address the fragmentation of health care for multimorbid older people.

BMC GERIATRICS (2023)

Add to Collection

Article Primary Health Care

Scaling Up Patient-Centered Interdisciplinary Care for Multimorbidity: A Pragmatic Mixed-Methods Randomized Controlled Trial

Martin Fortin, Moira Stewart, Patrice Ngangue, Jose Almirall, Mathieu Belanger, Judith Belle Brown, Martine Couture, Frances Gallagher, Alan Katz, Christine Loignon, Bridget L. Ryan, Tara Sampalli, Sabrina T. Wong, Merrick Zwarenstein

Summary: This study evaluated the effectiveness of a 4-month interdisciplinary intervention for patients with multimorbidity in primary care practices. The quantitative analysis showed a neutral effect on the primary outcomes but significant improvement in two health behaviors. Qualitative evaluation revealed that patients reinforced their self-efficacy and improved their self-management, diverging from the quantitative results. The combination of qualitative and quantitative designs proved to be effective in evaluating the complex intervention.

ANNALS OF FAMILY MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets

Barry A. Borlaug, Michael D. Jensen, Dalane W. Kitzman, Carolyn S. P. Lam, Masaru Obokata, Oliver J. Rider

Summary: Obesity and heart failure with preserved ejection fraction (HFpEF) are two intertwining epidemics, and obesity may have widespread effects on the cardiovascular system, leading to symptomatic HFpEF. Understanding the pathophysiological mechanisms of obese HFpEF is crucial for developing new therapeutic approaches.

CARDIOVASCULAR RESEARCH (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial

Toru Kondo, Karola S. Jering, C. Jan Willem Borleffs, Rudolf A. de Boer, Brian L. Claggett, Akshay S. Desai, Dan Dobreanu, Silvio E. Inzucchi, Adrian F. Hernandez, Stefan P. Janssens, Pardeep S. Jhund, Mikhail N. Kosiborod, Carolyn S. P. Lam, Anna Maria Langkilde, Felipe A. Martinez, Magnus Petersson, Pham Nguyen Vinh, Muthiah Vaduganathan, Scott D. Solomon, John J. V. McMurray

Summary: This study investigated how patient characteristics and outcomes vary according to the duration of heart failure, and compared the efficacy and safety of dapagliflozin in different stages of heart failure. The results showed that patients with longer-duration heart failure were older, had more comorbidities, and experienced worse symptoms. Dapagliflozin had consistent benefits across different stages of heart failure.

CIRCULATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation

Toru Kondo, Karola S. Jering, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Carolyn S. P. Lam, Aldo P. Maggioni, Felipe A. Martinez, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faiez Zannad, Michael R. Zile, Scott D. Solomon, John J. V. McMurray

Summary: This study validated a simple risk model for predicting stroke risk in heart failure patients with preserved ejection fraction but without atrial fibrillation. The results showed that the risk for stroke increased with increasing risk score, suggesting the use of anticoagulation therapy in high-risk patients.

CIRCULATION-HEART FAILURE (2023)

Add to Collection

Letter Endocrinology & Metabolism

Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study

Su-Yen N. Goh, Mikhail Kosiborod, Carolyn S. P. A. Lam, Matthew Cavender, Shun Kohsaka, Anna Norhammar, Kare I. W. Birkeland, Reinhard Holl, Didac Mauricio, Navdeep E. Tangri, Jonathan Shaw, Marcus Thuresson, Peter Fenici, Dae Jung Kim

DIABETES OBESITY & METABOLISM (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction

Riccardo M. Inciardi, Martin Abanda, Amil M. Shah, Maja Cikes, Brian Claggett, Hicham Skali, Muthiah Vaduganathan, Narayana Prasad, Sheldon Litwin, Bela Merkely, Annamaria Kosztin, Klaudia Vivien Nagy, Sanjiv J. Shah, Wilfred Mullens, Michael R. Zile, Carolyn S. P. Lam, Marc A. Pfeffer, John J. V. McMurray, Scott D. Solomon, PARAGON HF Investigators

Summary: This study aimed to evaluate the clinical implications of right ventricular function and its association with NT-proBNP, as well as its risk for adverse events in patients with HFpEF. The results demonstrated that worsening RV function and its ratio to pulmonary pressure were significantly associated with an increased risk of HF hospitalizations and cardiovascular death in these patients.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction

Matteo Pagnesi, Marco Metra, Alain Cohen-Solal, Christopher Edwards, Marianna Adamo, Daniela Tomasoni, Carolyn S. P. Lam, Ovidiu Chioncel, Rafael Diaz, Gerasimos Filippatos, Piotr Ponikowski, Karen Sliwa, Adriaan A. Voors, Antoine Kimmoun, Maria Novosadova, Koji Takagi, Marianela Barros, Albertino Damasceno, Hadiza Saidu, Etienne Gayat, Peter S. Pang, Jelena Celutkiene, Gad Cotter, Alexandre Mebazaa, Beth Davison

Summary: This study demonstrates that a strategy of rapid uptitration of oral treatment for heart failure and close follow-up, compared with usual care, can significantly improve the prognosis of patients with acute heart failure, regardless of left ventricular ejection fraction. This approach reduces the risk of HF rehospitalization or all-cause death within 180 days after AHF hospitalization, independently of LVEF.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Fully Automated Artificial Intelligence Assessment of Aortic Stenosis by Echocardiography

Hema Krishna, Kevin Desai, Brody Slostad, Siddharth Bhayani, Joshua H. Arnold, Wouter Ouwerkerk, Yoran Hummel, Carolyn S. P. Lam, Justin Ezekowitz, Matthew Frost, Zhubo Jiang, Cyril Equilbec, Aamir Twing, Patricia A. Pellikka, Leon Frazin, Mayank Kansal

Summary: Aortic stenosis is a common heart valve disease, and the use of artificial intelligence technology can accurately evaluate the severity of the disease, improving the accuracy of diagnosis and treatment.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA

Javed Butler, Yinggan Zheng, Muhammad Shahzeb Khan, Diana Bonderman, Lars H. Lund, Christopher R. deFilippi, Robert O. Blaustein, Justin A. Ezekowitz, Cecilia Freitas, Adrian F. Hernandez, Christopher M. O'Connor, Adriaan A. Voors, Cynthia M. Westerhout, Carolyn S. P. Lam, Paul W. Armstrong, VICTORIA Study Grp

Summary: This study assessed the association between biomarker levels and outcomes in patients with lower left ventricular ejection fraction (LVEF), and examined the efficacy of vericiguat across different LVEF tertiles. The results showed that patients with lower LVEF had higher biomarker levels and a higher risk of adverse clinical outcomes. Vericiguat did not show a significant difference in efficacy across LVEF tertiles.

JACC-HEART FAILURE (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Kidney-Heart Connection Implications of Chronic Kidney Disease for Screening and Prevention of Heart Failure

Katherine R. Tuttle, Carolyn S. P. Lam

JACC-HEART FAILURE (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

How to Manage Heart Failure With Preserved Ejection Fraction Practical Guidance for Clinicians

Akshay S. Desai, Carolyn S. P. Lam, John J. V. McMurray, Margaret M. Redfield

Summary: Although patients with HFpEF have historically had limited treatment options, the emerging data from recent randomized trials have greatly expanded the range of pharmacologic options. Clinicians are in need of practical guidance for managing this growing population, and this review provides a contemporary framework based on the latest evidence and guidelines. Where data is lacking, the authors provide the best available information from post hoc analyses or observational studies to guide management until more definitive studies are conducted.

JACC-HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER

Jawad H. Butt, Kieran F. Docherty, Brian L. Claggett, Akshay S. Desai, Magnus Petersson, Anna Maria Langkilde, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Lars Kober, Carolyn S. P. Lam, Felipe A. Martinez, Piotr Ponikowski, Marc S. Sabatine, Sanjiv J. Shah, Muthiah Vaduganathan, Pardeep S. Jhund, Scott D. Solomon, John J. V. McMurray

Summary: This study found that gout is common in patients with heart failure and sodium-glucose cotransporter 2 inhibitors can reduce uric acid levels. Gout was associated with worse clinical outcomes, but the efficacy of dapagliflozin was consistent in patients with and without gout. Dapagliflozin also reduced the initiation of new treatments for hyperuricemia and gout.

JAMA CARDIOLOGY (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Left ventricular ejection fraction in women: when normal isn't normal

Carolyn S. P. Lam, Peder Langeland Myhre

HEART (2023)

Add to Collection

Correction Cardiac & Cardiovascular Systems

Corrigendum to: Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (vol 29, pg 275, 2022)

Massimo F. Piepoli, Marianna Adamo, Andrea Barison, Reinaldo B. Bestetti, Jan Biegus, Michael Bohm, Javed Butler, Jonathan Carapetis, Claudio Ceconi, Ovidiu Chioncel, Andrew Coats, Maria G. Crespo-Leiro, Giovanni de Simone, Heinz Drexel, Michele Emdin, Dimitros Farmakis, Martin Halle, Stephane Heymans, Tiny Jaarsma, Ewa Jankowska, Mitja Lainscak, Carolyn S. P. Lam, Maja-Lisa Lochen, Yuri Lopatin, Aldo Maggioni, Benedetta Matrone, Marco Metra, Katharine Noonan, Ileana Pina, Eva Prescott, Giuseppe Rosano, Petar M. Seferovic, Karen Sliwa, Simon Stewart, Alicia Uijl, Ilonca Vaartjes, Roel Vermeulen, W. M. Verschuren, Maurizio Volterrani, Stephan Von Haehling, Arno Hoes

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Add to Collection

Correction Cardiac & Cardiovascular Systems

Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions (vol 118, pg 3403, 2022)

Anthony E. Peters, Jasper Tromp, Sanjiv J. Shah, Carolyn S. P. Lam, Gregory D. Lewis, Barry A. Borlaug, Kavita Sharma, Ambarish Pandey, Nancy K. Sweitzer, Dalane W. Kitzman, Robert J. Mentz

CARDIOVASCULAR RESEARCH (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors

Mei-zhen Wu, Tiew-Hwa Katherine Teng, Christopher Tze-Wei Tsang, Yap-Hang Chan, Chi-Ho Lee, Qing-wen Ren, Jia-Yi Huang, Iok-fai Cheang, Yi-Kei Tse, Xin-li Li, Xin Xu, Hung-Fat Tse, Carolyn S. P. Lam, Kai-Hang Yiu

Summary: Our study provides real-world evidence that compared with DPP-4 inhibitors, SGLT2 inhibitors were associated with lower risk of hyperkalaemia and did not increase the incidence of hypokalaemia in patients with T2DM.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.